489 related articles for article (PubMed ID: 9844704)
1. COX-1 and COX-2 inhibition: current status and future perspective.
Greyn J; Lauwers MH; Vanlersberghe C; Camu F
Acta Anaesthesiol Belg; 1998; 49(3):175-83. PubMed ID: 9844704
[No Abstract] [Full Text] [Related]
2. The discovery and function of COX-2.
Needleman P; Isakson PC
J Rheumatol Suppl; 1997 Jul; 49():6-8. PubMed ID: 9249644
[No Abstract] [Full Text] [Related]
3. [In vivo selectivity of nonsteroidal anti-inflammatory drugs on COX-1-COX-2 and gastrointestinal ulcers, in rats].
Laudanno OM; Cesolari JA; Esnarriaga J; Flaherty P; Vada J; Guastalli G; San Miguel P; Bedini OA
Acta Gastroenterol Latinoam; 1998; 28(3):249-55. PubMed ID: 9773153
[TBL] [Abstract][Full Text] [Related]
4. COX-2 inhibitors: new drugs for the management of pain and inflammation.
Hutchins V; Hutchins B
Dent Today; 2001 Feb; 20(2):56-61. PubMed ID: 12524847
[No Abstract] [Full Text] [Related]
5. [Specificity, action, indications and safety. Criteria for the use of COX-2 inhibitors].
Wigand R
Pharm Unserer Zeit; 2002; 31(2):190-8. PubMed ID: 11977455
[No Abstract] [Full Text] [Related]
6. The future of NSAID therapy: selective COX-2 inhibitors.
Vane JR; Botting RM
Int J Clin Pract; 2000; 54(1):7-9. PubMed ID: 10750251
[No Abstract] [Full Text] [Related]
7. COX-2 inhibitors--is there cause for concern?
Seibert K; Lefkowith J; Tripp C; Isakson P; Needleman P
Nat Med; 1999 Jun; 5(6):621-2. PubMed ID: 10371498
[No Abstract] [Full Text] [Related]
8. New NSAIDs and gastroduodenal damage.
Folco GC
Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():28-9. PubMed ID: 9032579
[TBL] [Abstract][Full Text] [Related]
9. [New NSAIDS: COX-1, COX-2, what about them?].
Peretz A
Rev Med Brux; 1998 Sep; 19(4):A399-402. PubMed ID: 9805982
[TBL] [Abstract][Full Text] [Related]
10. [Cyclooxygenases in the spinal cord and the relationship with pain].
Li SQ; Li WB
Sheng Li Ke Xue Jin Zhan; 2003 Oct; 34(4):359-60. PubMed ID: 14992024
[No Abstract] [Full Text] [Related]
11. Nonsteroidal anti-Inflammatory drugs and cardiovascular risk.
Howard PA; Delafontaine P
J Am Coll Cardiol; 2004 Feb; 43(4):519-25. PubMed ID: 14975457
[TBL] [Abstract][Full Text] [Related]
12. COX-1 and COX-2 in health and disease.
Adelizzi RA
J Am Osteopath Assoc; 1999 Nov; 99(11 Suppl):S7-12. PubMed ID: 10643175
[TBL] [Abstract][Full Text] [Related]
13. New directions in cyclooxygenase research and their implications for NSAID-gastropathy.
Flower RJ
Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():23-7. PubMed ID: 9032578
[TBL] [Abstract][Full Text] [Related]
14. [COX-1 and COX-2: functions and pharmacological effects].
Hinz B; Brune K
Pharm Unserer Zeit; 1999 Jan; 28(1):21-9. PubMed ID: 10078026
[No Abstract] [Full Text] [Related]
15. COX-2 inhibitors: no pain, no heart gain?
Harv Heart Lett; 2001 Dec; 12(4):2-4. PubMed ID: 11751079
[No Abstract] [Full Text] [Related]
16. Cox-2-selective inhibitors: the new super aspirins.
DeWitt DL
Mol Pharmacol; 1999 Apr; 55(4):625-31. PubMed ID: 10101019
[No Abstract] [Full Text] [Related]
17. [COX-2 inhibitor to whom?].
Martio J
Duodecim; 2000; 116(12):1265-7. PubMed ID: 11988961
[No Abstract] [Full Text] [Related]
18. Inhibition of cyclooxygenase (COX) enzymes by compounds from Daucus carota L. Seeds.
Momin RA; De Witt DL; Nair MG
Phytother Res; 2003 Sep; 17(8):976-9. PubMed ID: 13680840
[TBL] [Abstract][Full Text] [Related]
19. NSAIDs and alcohol: never the twain shall mix?
Pfau PR; Lichenstein GR
Am J Gastroenterol; 1999 Nov; 94(11):3098-101. PubMed ID: 10566697
[No Abstract] [Full Text] [Related]
20. Role of cyclooxygenase-1 and -2 in health and disease.
Lipsky PE
Am J Orthop (Belle Mead NJ); 1999 Mar; 28(3 Suppl):8-12. PubMed ID: 10193997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
